Literature DB >> 10457385

Herpes simplex virus encephalitis: chronic progressive cerebral MRI changes despite good clinical recovery and low viral load - an experimental mouse study.

U Meyding-Lamadé1, W Lamadé, R Kehm, C Oberlinner, A Fäth, B Wildemann, J Haas, W Hacke.   

Abstract

Cranial magnetic resonance imaging (MRI) is a sensitive diagnostic tool for the in vivo detection of morphological abnormalities in herpes simplex virus encephalitis (HSVE). We performed a long-term MRI study in a mouse model of HSVE. Cranial MRI findings were compared with the viral load within brain tissue, the presence of HSV DNA in the cerebrospinal fluid (CSF), a daily clinical assessment and post-mortem neurohistopathological studies. A 1.5 T cranial MRI scanner with standard spin-echo sequences was used. Viral load within the brain and the presence of HSV DNA in cerebrospinal fluid were determined by a polymerase chain reaction assay. Clinically, animals were severely affected within the first 2 weeks and recovered thereafter. Focal histopathological and MRI abnormalities involved predominantly limbic structures, a pattern that mimics human disease. Severity and extent of abnormalities had increased at 6 months despite clinical improvement. HSV DNA was present in CSF during the acute disease only. Brain viral load peaked at day 10 and declined thereafter. MRI as an in vivo monitoring approach may reveal chronic progressive changes in HSVE, despite clinical recovery and low viral load in the brain. Secondary, not directly virus-mediated, mechanisms of tissue damage may contribute to tissue damage of HSVE. Copyright Lippincott Williams & Wilkins

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10457385     DOI: 10.1046/j.1468-1331.1999.650531.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  12 in total

1.  Experimental herpes simplex virus encephalitis: a combination therapy of acyclovir and glucocorticoids reduces long-term magnetic resonance imaging abnormalities.

Authors:  Uta K Meyding-Lamadé; Christoph Oberlinner; Philipp R Rau; Sonja Seyfer; Sabine Heiland; Johann Sellner; Brigitte T Wildemann; Wolfram R Lamadé
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

2.  The case for immunomodulatory approaches in treating HSV encephalitis.

Authors:  Chandran Ramakrishna; Harry Openshaw; Edouard M Cantin
Journal:  Future Virol       Date:  2013-03-01       Impact factor: 1.831

3.  Spatiotemporal changes of the herpes simplex virus entry receptor nectin-1 in murine brain during postnatal development.

Authors:  Szatmár Horváth; Emese Prandovszky; Zsolt Kis; Claude Krummenacher; Roselyn J Eisenberg; Gary H Cohen; Zoltán Janka; József Toldi
Journal:  J Neurovirol       Date:  2006-06       Impact factor: 2.643

4.  Differences in pathogenicity of herpes simplex virus serotypes 1 and 2 may be observed by histopathology and high-resolution magnetic resonance imaging in a murine encephalitis model.

Authors:  H C Thomas; R D Kapadia; G I Wells; A M Gresham; D Sutton; H A Solleveld; S K Sarkar; S B Dillon; R Tal-Singer
Journal:  J Neurovirol       Date:  2001-04       Impact factor: 2.643

5.  Quantitative diffusion tensor imaging in herpes simplex virus encephalitis.

Authors:  C Herweh; M R Jayachandra; M Hartmann; A Gass; J Sellner; S Heiland; S Nagel; St Hähnel; U Meyding-Lamadé
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

6.  Chronic cortical and subcortical pathology with associated neurological deficits ensuing experimental herpes encephalitis.

Authors:  Anibal G Armien; Shuxian Hu; Morgan R Little; Nicholas Robinson; James R Lokensgard; Walter C Low; Maxim C-J Cheeran
Journal:  Brain Pathol       Date:  2009-11-05       Impact factor: 6.508

Review 7.  Mechanisms of Blood-Brain Barrier Disruption in Herpes Simplex Encephalitis.

Authors:  Hui Liu; Ke Qiu; Qiang He; Qiang Lei; Wei Lu
Journal:  J Neuroimmune Pharmacol       Date:  2018-11-19       Impact factor: 4.147

8.  Aquaporin 4 regulation during acute and long-term experimental Herpes simplex virus encephalitis.

Authors:  F J Martinez Torres; D Völcker; N Dörner; Th Lenhard; S Nielsen; J Haas; K Kiening; U Meyding-Lamadé
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

9.  In vivo monitoring of acute flavivirus (Modoc) encephalitis with regional and whole-brain quantitative diffusion magnetic resonance imaging.

Authors:  Johann Sellner; Pieter Leyssen; Sabine Heiland; Philipp Rau; Johan Neyts; Francisco Martinez-Torres; Peter Schramm; Werner Hacke; Uta Meyding-Lamadé
Journal:  J Neurovirol       Date:  2004-08       Impact factor: 2.643

10.  Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933].

Authors:  Francisco Martinez-Torres; Sanjay Menon; Maria Pritsch; Norbert Victor; Ekkehart Jenetzky; Katrin Jensen; Eva Schielke; Erich Schmutzhard; Jan de Gans; Chin-Hee Chung; Steffen Luntz; Werner Hacke; Uta Meyding-Lamadé
Journal:  BMC Neurol       Date:  2008-10-29       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.